Back to Immune System Table of Contents
PCB Human Health Risks
Fox River Watch
Site Index
Please give page time to load

monkey immune system, monkey immunity, primate immune system, primate immunity
monkey immune system, monkey immunity, primate immune system, primate immunity

Monkey Immune System Damage from PCBs

monkey immune system, monkey immunity, primate immune system, primate immunity

All 8 studies listed below show that very low levels of PCB exposure can cause changes in the monkey immune system, which is very similar to a human's.  These studies show that even slight effects could be important for susceptible people or those with existing health problems. The fetus and young infants are especially vulnerable to PCB exposure in the womb or through breastfeeding, but even adults can be sensitive to PCB immune effects.

For more information, see Introduction.

monkey immune system, monkey immunity, primate immune system, primate immunity
Summary of Results --- 8 Studies of PCB Effects 

(Each entry represents one finding in a study --- unless otherwise noted. Some studies had multiple findings.)

  • low PCB levels change the immune system
  • adult nonhuman primates are sensitive to the immunotoxic effects of low levels of PCBs
  • serum hemolytic complement activity in all PCB treated groups was significantly higher
  • significant dose-related increase in natural killer cell activity
  • significant dose-related increase in thymosin alpha-1 levels
  • significant increased interferon levels
  • sustained low-level PCB exposure could have modest to slight immunosuppressive effects, which might be important depending on the general health of the individual.
  • significantly lower anti-SRBC antibody titers
  • consistently lower gamma-globulin levels
  • impaired ability to withstand challenge by pathogens and an increased sensitivity to endotoxin.
  • changes in a number of hematologic, serum chemistry, and immune function variables at doses lower than previously reported for nonhuman primates.
  • significant decrease in erythrocyte and reticulocyte counts, hematocrits, mean platelet volumes, serum cholesterol and total bilirubin concentrations
  • significant decrease in IgG, IgA, and IgM antibody responses
  • significant increase in the T-cytotoxic and T-suppressor ratio
  • significant increases in the alpha1 and alpha2 globulin concentrations
  • infants showed immunological test differences
  • low level chronic PCB exposure causes moderate changes in several parameters of immune system function in rhesus-monkeys
  • significant dose related decrease in the IgM and IgG response to conA and PHA
  • monocyte response to PMA was significantly increased in a dose related manner
  • mean proportion of CD2 cells was significantly decreased
  • PCB Aroclor-1254 has a direct effect on the immune system
  • significant dose dependent decreases in antibody responses
  • increases in CD8 positive T-cells and decreases in CD4 positive T-cells along with the CD48 ratio
  • serum levels of thymosin-alpha-1 showed a significant dose dependent increase
  • decreased levels of thymidine incorporation by mitogen induced proliferating lymphocytes and decreased mononuclear cell phagocytic activity
  • significant increases in natural killer cell activity
  • monkeys fed "purified" PCBs suffered immune suppression, as did those fed "pure" furans, or polychlorinated quaterphenyls (therefore, it isn’t just the furans causing the problem)
  • decreased antibodies --- immunoglobulin-M (IgM) and immunoglobulin-G (IgG)
  • significant increases in absolute and percent T-suppressor (Ts) cells
  • reduction in the percent T-helper (Th) cells
monkey immune system, monkey immunity, primate immune system, primate immunity
The Monkey Studies

This is not a complete list of all studies on this topic. For more studies, visit the TOXNET database operated by the National Library of Medicine (the source of these abstracts). 

Study #1

  • low PCB levels change the immune system
  • serum hemolytic complement activity in all PCB treated groups was significantly higher
  • significant dose-related increase in natural killer cell activity
  • significant dose-related increase was noted for thymosin alpha-1 levels
  • significant increased interferon levels
The effects of low level, chronic polychlorinated biphenyl--Aroclor 1254--(PCB) exposure were investigated on non-specific immune parameters in female rhesus (Macaca mulatta) monkeys. Five groups of monkeys were orally administered with PCB at concentrations of 0, 5, 20, 40 or 80 micrograms/kg bw/day. Immunotoxicity testing was initiated after 55 months of exposure. The serum hemolytic complement activity in all PCB treated groups was significantly higher (P less than 0.05) than that in the control group. A statistically significant dose-related increase in natural killer cell activity was evident at the 75:1 effector to target cell ratio. Similarly, a statistically significant dose-related increase was noted for thymosin alpha-1 levels but not for thymosin beta-4 levels. Statistically significant increased interferon levels were noted in the 20 and 80 micrograms/kg groups compared with the control group while the levels in the 40 micrograms/kg group were decreased significantly compared with the con (Tryphonas et al, 1991)

Study #2

  • sustained low-level PCB exposure could have modest to slight immunosuppressive effects, which might be important depending on the general health of the individual.
  • significantly lower anti-SRBC antibody titers
  • consistently lower gamma-globulin levels
  • impaired ability to withstand challenge by pathogens and an increased sensitivity to endotoxin.
Female rhesus monkeys were fed either normal chow or chow containing 2.5 or 5.0 ppm of Aroclor 1248 (PCB (polychlorinated biphenyl; environmental pollutant)). After 6 mo., the PCB-fed monkeys developed chloracne, alopecia and facial edema. After 11 mo., control and treated monkeys were immunized with sheep red blood cells (SRBC) and tetanus toxoid (TT). Monkeys fed 5.0 ppm of PCB had significantly lower anti-SRBC antibody titers than controls at only 2 intervals following primary immunization. Antibody response to TT was not measurably affected by PCB exposure. Both PCB-fed groups had consistently lower gamma-globulin levels than controls. Sustained exposure to low levels of PCB could have modest to slight immunosuppressive effects, which might be important depending on the general health of the individual. Mice fed up to 1000 ppm of PCB for 3-5 wk exhibited no signs of PCB intoxication other than liver hypertrophy. However, these mice, when challenged with Salmonella typhimurium, showed higher mortality and significantly greater numbers of viable organisms in the spleen, liver and blood than did controls. Similarly, exposed mice showed an increased sensitivity to endotoxin. Mice exposed to subclinical doses of PCB (i.e., doses insufficient to produce overt clinical signs of intoxication) appear to have an impaired ability to withstand challenge by pathogens and an increased sensitivity to endotoxin. (Thomas et al, 1978)

Study #3

  • changes in a number of hematologic, serum chemistry, and immune function variables at doses lower than previously reported for nonhuman primates.
  • significant decrease in erythrocyte and reticulocyte counts, hematocrits, mean platelet volumes, serum cholesterol and total bilirubin concentrations
  • significant decrease in IgG, IgA, and IgM antibody responses
  • significant increase in the T-cytotoxic and T-suppressor ratio
  • significant increases in the alpha1 and alpha2 globulin concentrations.
Hematological, biochemical, and hormonal changes resulting from ingestion of aroclor-1254 (11097691) (aroclor) during the prebreeding phase were studied in female rhesus-monkeys (Macaca-mulatta). The study was part of a 6.5 year investigation of the effects of prenatal and lactational polychlorinated biphenyl (PCB) exposure in rhesus-monkeys. Eighty menstruating female monkeys, average age 11.1 years, ingested capsules containing 0, 5, 20, 40, or 80 micrograms per kilogram aroclor daily until steady state PCB concentrations in their adipose tissue were obtained. Blood samples were collected at monthly or bimonthly intervals to determine standard hematologic and serum biochemical parameters, serum hydrocortisone concentrations, and immunoglobulin-A (IgA), immunoglobulin-G (IgG), and immunoglobulin-M (IgM) antibody concentrations in response to sheep red blood cell immunization. Differential serum protein analyses and thyroid evaluations were performed at these times. Serum estrogen and progesterone concentrations were determined during one menstrual cycle. Skin biopsies were obtained from the scapular area 1 month before and 10 and 20 months after the start of dosing to examine the effects of aroclor on sebaceous gland area. Aroclor significantly decreased erythrocyte and reticulocyte counts, hematocrits, mean platelet volumes, serum cholesterol and total bilirubin concentrations, and IgG, IgA, and IgM antibody responses to sheep red blood cells. The T-cytotoxic and T-suppressor ratios were significantly increased. Among the serum protein fractions, aroclor induced significant increases in the alpha1 and alpha2 globulin concentrations. No significant effects on serum estrogen or progesterone concentrations during menstrual cycling were detected. Aroclor did not significantly affect any of the variables associated with thyroid function. Aroclor significantly decreased the number of sebaceous gland lobules per histological length after 20 months of dosing. The authors conclude that aroclor produces changes in a number of hematologic, serum chemistry, and immune function variables in rhesus-monkeys at doses lower than previously reported for nonhuman primates. (Arnold et al, 1993)

Study #4

  • infants showed immunological test differences
A group of 80 menstruating rhesus (Macaca mulatta) monkeys were randomly allocated to four similar test rooms (20 monkeys/room) and then randomly allocated within each room to one of five dose groups (four females/dose group/room). Each day, the monkeys self-ingested capsules containing doses of 0, 5, 20, 40 or 80 micrograms Aroclor 1254/kg body weight. After 25 months of continuous dosing, approximately 90% of the treated females had attained a qualitative pharmacokinetic steady state with respect to the concentration of polychlorinated biphenyl (PCB) in their adipose tissue. Commencing on test month 37, each female was paired with an untreated male until either an impregnation occurred or the 29-month breeding phase of the study was completed. The females continued to receive their daily test dose during mating and gestation. To preclude an infant ingesting the mother's dosing capsule, dosing of the dam was discontinued when a nursing infant was approximately 7 wk old. Treatment was restarted when the infant was weaned at 22 wk of age. At parturition, and every 4 wk until weaning, milk and blood samples were obtained from the dam and a blood sample was obtained from the infant for PCB analysis. When the infant was 20 wk old, immunological testing was initiated and an adipose sample was obtained from the infant and dam for PCB analysis. Subsequently, further adipose and blood samples were obtained from the infant and blood specimens were obtained from the dam for PCB analysis. Concurrently, each infant was subjected to anthropometric measurements and detailed clinical examinations until it was approximately 122 wk old. At 122 wk some of the control and all of the treated infants were killed humanely and autopsied. A statistical analysis of the reproduction data provided evidence for a significant decreasing dose-related trend in conception rates and a significant increasing dose-related trend in foetal mortality. Several comparisons between impregnated and non-impregnated females did not implicate 'age' as a confounding factor regarding these results. The major findings with the infants involved some immunological test differences and mild clinical manifestations of PCB ingestion. (Arnold et al, 1995)

Study #5

  • low level chronic PCB exposure causes moderate changes in several parameters of immune system function in rhesus-monkeys
  • significant dose related decrease in the IgM and IgG response to conA and PHA
  • monocyte response to PMA was significantly increased in a dose related manner
  • mean proportion of CD2 cells was significantly decreased
The immunomodulatory effects of aroclor-1254 (11097691) were studied in monkeys. Female rhesus-monkeys were administered 0, 5, 20, 40, or 80 micrograms per kilogram (microg/kg) aroclor-1254 daily. Peripheral blood samples were collected after 55 months and assayed for aroclor-1254. The effects on immune function were assessed at this time by determining the immunoglobulin-M (IgM) and immunoglobulin-G (IgG) responses to sheep red blood cells (SRBCs), the antibody response to pneumococcal antigen, the lymphocyte proliferative response to concanavalin-A (conA), phytohemagglutinin (PHA), and pokeweed-mitogen, the mixed lymphocyte response, the monocytic response to zymosan or phorbol-myristate-acetate (PMA), and the production of interleukin-1. A flow cytometric analysis of peripheral blood leukocyte subpopulations was performed. Serum hydrocortisone concentrations were measured. Eleven of 80 monkeys were removed from the study because they developed endometriosis, cervical cancer, and polychlorinated biphenyl (PCB) toxicity. Blood aroclor-1254 concentrations ranged from 21.276 parts per million (ppm) in the 5microg/kg group to 285.919 ppm in the 80 microg/kg dose group. Aroclor-1254 caused a significant dose related decrease in the IgM and IgG response to conA and PHA. The monocyte response to zymosan stimulation was nonsignificantly increased. The monocyte response to PMA was significantly increased in a dose related manner. The mean proportion of CD2 cells was significantly decreased by aroclor-1254; however, the absolute number of CD2 cells was unaffected. None of the other parameters of immune system function was significantly affected by aroclor-1254. The authors conclude that low level chronic PCB exposure causes moderate changes in several parameters of immune system function in rhesus-monkeys. These changes may reflect alterations in T-cell or macrophage function. (Tryphonas et al, 1991)

Study #6

  • adult nonhuman primates are sensitive to the immunotoxic effects of low levels of PCBs
  • PCB Aroclor-1254 has a direct effect on the immune system
  • significant dose dependent decreases in antibody responses
  • increases in CD8 positive T-cells and decreases in CD4 positive T-cells along with the CD48 ratio
  • serum levels of thymosin-alpha-1 showed a significant dose dependent increase
  • decreased levels of thymidine incorporation by mitogen induced proliferating lymphocytes and decreased mononuclear cell phagocytic activity
  • significant increases in natural killer cell activity
The use of nonhuman primates as an appropriate animal model to study the metabolism and accumulation of polychlorinated biphenyls (PCBs) was examined. The metabolism and toxic effects of low doses of PCBs were studied in female Rhesus-monkeys orally administered up to 80 micrograms per kilogram Aroclor-1254 (27323188) per day. Immunological effects were noted with the establishment of a blood PCB pharmacokinetic equilibrium at 23 months of exposure and 55 months into the study. The blood PCB concentration noted at 23 months of the study remained at similar levels 55 months into the study. Significant dose dependent decreases in antibody responses to sheep erythrocytes were observed. Changes in T-cell subsets included increases in CD8 positive T-cells and decreases in CD4 positive T-cells along with the CD48 ratio. Lymphocyte proliferation to alloantigens, repeated measurements of total serum immunoglobulin levels, and serum protein fractions did not prove to be sensitive indicators for the possible effects of Aroclor-1254 on T-cell function. Serum levels of thymosin-alpha-1 showed a significant dose dependent increase. A trend toward decreased levels of thymidine incorporation by mitogen induced proliferating lymphocytes and decreased mononuclear cell phagocytic activity was noted. Significant increases in natural killer cell activity were observed only in the high dose animals and only at a specific effector/target cell ratio. Significant dose dependent increases in serum complement activity were recognized after 55 months of exposure. PCB treatment did not affect serum levels of corticosteroids in the monkeys, suggesting a direct effect of Aroclor-1254 on the immune system. The author concludes that nonhuman primates are sensitive to the immunotoxic effects of low levels of PCBs. (Tryphonas et al, 1995)

Study #7

  • monkeys fed "purified" PCBs suffered immune suppression, as did those fed "pure" furans, or polychlorinated quaterphenyls  (therefore, it isn’t just the furans causing the problem)
Effects on humans: In Japan, in 1968, mass consumption of a cooking oil (Kameni Rice Oil) contaminated with PCB (~2500 ug.L-1 of Kanechlor 400 (KC 400) previously used as a heat transfer agent) caused an outbreak of a disease known as "Yusho" which affected over 1000 people (Hayabuchi et al. 1979; Kuratsune et al. 1972). Later this disease was attributed at least in part to the 40 tri to hexa PCDFs (including 2,3,7,8-T4CDF, 2,3,4,7,8-P5CDF and 2,3,4,6,7-P5CDF as major components) which also contaminated the oil at levels up to 5 ug.L-1 (Nagayama et al. 1976; Rappe et al. 1977; Buser et al. 1978c; Masuda et al. 1982). It has been estimated that Yusho patients consumed an average of 3.4 mg PCDF (48 ug.kg-BW-1 for a 70 kg man) (Hayabuchi et al. 1979); 2,3,4,7,8-P5CDF was the major component. PCDFs have been found in tissue from Yusho patients at ng.kg-1 levels (Chapter 6). The initial toxic clinical symptoms included swelling of the eyelids and eye discharge, acne, swelling of limbs, digestive disruptions, numbness and other neurological signs, and skin pigmentation (Kuratsune et al. 1972). In 1979, a similar episode also involving PCB contaminated rice oil was reported from Taiwan; about 200 people were involved (Wong et al 1982). The levels of PCBs (Kanechlor 400 and 500) and PCDFs were somewhat lower in the Taiwan oil, about 100 and 0.1 ug.L-1 respectively (Masuda et al. 1982), but the isomer spectrum was similar. The occurrence and severity of the toxic response in Japan correlated with the estimated amount of oil consumed (Kuratsune et al. 1972; Hayabuchi et al. 1979) but not at all with the amount of oil consumed per kg-BW per day (Hayabuchi et al. 1979). This may reflect the ability of the highly-chlorinated PCBs and PCDFs to accumulate in the body. It is interesting to note that the latent period before the onset of toxic symptoms showed a negative correlation with the amount of oil consumed per kg per day, in accord with general principles of toxicology but in contrast to other aspects of PCDF toxicology, such as the latent period before death following administration of toxic doses to laboratory mammals (see Section 7.2.5). The signs and symptoms observed in these human patients resemble those described for laboratory primates (Section 7.2.1), including mucocutaneous pigmentation, acne, deformed nails and dry skin (Wong et al. 1982). Fischbein et al. (1982) reported that in 326 capacitor manufacturing workers a high prevalence (37%) of dermatological abnormalities was found. The symptoms included erythema, dryness and thickening of the skin, hyperpigmentation, rash, swelling and acne. When a subgroup of the most affected workers with skin abnormalities (thought to related to PCB exposure in particular) were compared with non-affected workers, a significant difference was found between the mean concentrations of the higher PCB homologues. PCDF concentrations were not investigated in this study but capacitor workers could be subject to high PCDF exposure (Section 5.2.2). It is not possible to draw firm conclusions about the effect of PCDFs on humans from incidents involving PCBs because in such cases the people are also exposed to the PCBs per se and other contaminants such as polychlorinated quaterphenyls (PCQs) in the case of Japanese Yusho. Although the PCDFs are generally much more toxic than the other chemicals, they are usually present in relatively small amounts. In Yusho oil the ratio of PCDF:PCQ:PCB was 1:160:500 (Kashimoto et al. 1981). Hori et al. (1982) attempted to clarify the effects of PCBs, PCQs and PCDFs by administering purified PCBs ("free" of PCDF), PCB contaminated with PCDFs, and PCQs, orally to monkeys (Macaca fascicularis) at 5 mg.d-1 for 20 weeks. In the groups fed purified PCB, immunosuppression and histopathological changes of the liver were observed. In the group receiving contaminated PCBs, there were more marked decreases in body weight, as well as immunosuppression and fatty liver and histopathological changes; in addition, hair loss, acne eruptions, edema of the eyelid, congestion of the Meibomian gland and other characteristic dermatological findings of Yusho disease were noted. In the group fed PCQs, there was immunosuppression as well as enlarged liver but no decrease in body weight or skin abnormalities. These results suggest that the PCDFs were probably largely responsible for the symptoms observed in Yusho disease. Toxicity to aquatic organisms: There are very few data on the toxicity of the PCDFs to aquatic organisms. Juvenile Atlantic salmon, fed a PCDF mixture in the diet (2.7 D2CDF, 5.7 T3CDF, 2.8 T4CDF, 9.1 O8CDF ug.g-diet-l), had a median mortality of 120 +/- 30 d (Zitko and Choi 1973). No mortality was observed when immature brook trout were given a single dose of 2,8-D2CDF at levels as high as 122 mg.kg-BW-1 (Zitko et al. 1973). Zitko et al. (1973) indicated that after dietary dosing, tri and tetra PCDFs were retained preferentially to 2,8-D2CDF in fish liver and muscle, with greatest retention in the liver. Fingerman and Fingerman (1977) reported that C8CDF at a concentration of 16 x 10E-6 ug.L-1 in the aquarium water slightly inhibited the rate of molting of the fiddler crab Uca pugilator. (McLeod et al, 1984)

Study #8

  • decreased antibodies --- immunoglobulin-M (IgM) and immunoglobulin-G (IgG)
  • significant increases in absolute and percent T-suppressor (Ts) cells
  • reduction in the percent T-helper (Th) cells
Preliminary results were reported concerning immunologic investigations in adult Rhesus-monkeys initiated at 23 months of age with daily exposure to Aroclor-1254 (11097691) at concentrations of 5.0, 20.0, 40.0, or 80.0 micrograms/kilogram (microg/kg). Studies were intended to determine the effects of low levels of the chemical on the immune system of the adults and their offspring who were exposed in-utero or through nursing. Analysis of antibody production indicated a statistically significant trend toward decreased antibody titers as the dose of Aroclor-1254 increased for the immunoglobulin-M (IgM) and immunoglobulin-G (IgG) class of antibodies to sheep red blood cells (SRBC). This effect was noted at all dose levels, even at 5.0microg/kg, suggesting a high degree of sensitivity of this assay in detecting subtle effects on the immune system. Significant increases occurred in the absolute and percent T-suppressor (Ts) cells with a concurrent reduction in the percent T-helper (Th) cells. B-Lymphocytes were not affected by the treatment. No significant differences were noted in the levels of total serum IgG and IgM. The treatment also had no significant effect on hydrocortisone levels or the total serum protein, albumin, or the alpha, beta and gamma globulins. Efforts are currently underway to determine the mechanism by which the chemical exerts its immunotoxic effects. (Tryphonas et al, 1989)

monkey immune system, monkey immunity, primate immune system, primate immunity
Other pages in this Immunity section:

monkey immune system, monkey immunity, primate immune system, primate immunity
Back to top
PCB Human Health Risks
Fox River Watch
Site Index
Make a Donation

monkey immune system, monkey immunity, primate immune system, primate immunity